Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up (Q33330934)
scientific article
Language:
Current Data About Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up
(P31) (Q13442814)
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P50) (Q30792585)
(P1545) 9
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(Q98073416)
(P1545) 2
(P1932) Braly P

(P304) 419-426
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P407) (Q1860)

(P433) 3
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P478) 75
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P577) Wednesday, December 1, 1999
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P921) (Q42824440)

(Q172341)
(P887)

(Q18936)
(P887)

(P1433) (Q5625182)
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P1476) "Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up" (language: en)
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

(P2093) Morgan RJ Jr
(P1545) 1
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Cecchi G
(P1545) 3
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Leong L
(P1545) 4
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Shibata S
(P1545) 5
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Margolin K
(P1545) 6
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Somlo G
(P1545) 7
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

McNamara M
(P1545) 8
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Schinke S
(P1545) 10
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Raschko J
(P1545) 11
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Nagasawa S
(P1545) 12
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Kogut N
(P1545) 13
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Parker P
(P1545) 14
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Stein A
(P1545) 15
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Cho J
(P1545) 16
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Smith E
(P1545) 17
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Coluzzi P
(P1545) 18
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Najera L
(P1545) 19
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Johnson D
(P1545) 20
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Womack E
(P1545) 21
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

Doroshow JH
(P1545) 22
(P248)
(P698) 10600300
(P813) Tuesday, July 25, 2017

other details
description scientific article

External Links
(P356) 10.1006/GYNO.1999.5613
(P698) 10600300